Dynamic increase of M2 macrophages is associated with disease progression of colorectal cancers following cetuximab-based treatment
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dynamic increase of M2 macrophages is associated with disease progression of colorectal cancers following cetuximab-based treatment
Authors
Keywords
-
Journal
Scientific Reports
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-31
DOI
10.1038/s41598-022-05694-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hedgehog-induced PD-L1 on tumor-associated macrophages is critical for suppression of tumor-infiltrating CD8+ T cell function
- (2021) Amy J. Petty et al. JCI Insight
- Photoimmunotherapy with cetuximab-conjugated gold nanorods reduces drug resistance in triple negative breast cancer spheroids with enhanced infiltration of tumor-associated macrophages
- (2020) Fakhrossadat Emami et al. JOURNAL OF CONTROLLED RELEASE
- Spatial Distribution and Prognostic Implications of Tumor-Infiltrating FoxP3- CD4+ T Cells in Biliary Tract Cancer
- (2020) Hyung-Don Kim et al. Cancer Research and Treatment
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets
- (2019) Luca Cassetta et al. CANCER CELL
- M2 macrophages mediate sorafenib resistance by secreting HGF in a feed-forward manner in hepatocellular carcinoma
- (2019) Ningning Dong et al. BRITISH JOURNAL OF CANCER
- Tumor-associated Macrophages as Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer
- (2019) Qingyang Feng et al. CLINICAL CANCER RESEARCH
- M2 macrophages confer resistance to 5-fluorouracil in colorectal cancer through the activation of CCL22/PI3K/AKT signaling
- (2019) Chen Wei et al. OncoTargets and Therapy
- Interaction of tumor-associated macrophages and cancer chemotherapy
- (2019) Irina Larionova et al. OncoImmunology
- Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal Cancer
- (2019) Andrew Woolston et al. CANCER CELL
- Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications
- (2019) Yuxin Lin et al. Journal of Hematology & Oncology
- Immune Resistance and EGFR Antagonists in Colorectal Cancer
- (2019) Giordano et al. Cancers
- Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
- (2019) NaNa Keum et al. Nature Reviews Gastroenterology & Hepatology
- Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients
- (2019) Steven M. Bray et al. Scientific Reports
- The Immune Landscape of Cancer
- (2018) Vésteinn Thorsson et al. IMMUNITY
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
- (2018) Franck Pagès et al. LANCET
- The colorectal cancer immune microenvironment and approach to immunotherapies
- (2017) Minoru Koi et al. Future Oncology
- Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells
- (2017) Peiming Zheng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
- (2017) Sydney R. Gordon et al. NATURE
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
- (2017) Michael A. Cannarile et al. Journal for ImmunoTherapy of Cancer
- Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells
- (2016) M. Baghdadi et al. CANCER RESEARCH
- The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death
- (2016) Chiara Pozzi et al. NATURE MEDICINE
- Polarization of macrophages in the tumor microenvironment is influenced by EGFR signaling within colon cancer cells
- (2016) Weina Zhang et al. Oncotarget
- Mechanisms of resistance to anti-EGFR therapy in colorectal cancer
- (2016) Ben Zhao et al. Oncotarget
- Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
- (2015) R. Hughes et al. CANCER RESEARCH
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- The pancreatic cancer secreted REG4 promotes macrophage polarization to M2 through EGFR/AKT/CREB pathway
- (2015) XIUYING MA et al. ONCOLOGY REPORTS
- Activation of the Epidermal Growth Factor Receptor in Macrophages Regulates Cytokine Production and Experimental Colitis
- (2014) N. Lu et al. JOURNAL OF IMMUNOLOGY
- GSVA: gene set variation analysis for microarray and RNA-Seq data
- (2013) Sonja Hänzelmann et al. BMC BIOINFORMATICS
- Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer
- (2013) Alberto Bardelli et al. Cancer Discovery
- Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
- (2012) Sandra Misale et al. NATURE
- The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
- (2012) Luis A. Diaz Jr et al. NATURE
- A Molecularly Annotated Platform of Patient-Derived Xenografts ("Xenopatients") Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer
- (2011) A. Bertotti et al. Cancer Discovery
- Insulin-like growth factor 1 expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab and irinotecan
- (2010) Mario Scartozzi et al. INTERNATIONAL JOURNAL OF CANCER
- Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members
- (2008) D L Wheeler et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search